Pathogenesis of Chagas Heart Disease

恰加斯心脏病的发病机制

基本信息

  • 批准号:
    7184326
  • 负责人:
  • 金额:
    $ 27.01万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2004
  • 资助国家:
    美国
  • 起止时间:
    2004-01-01 至 2008-12-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by the applicant): The protozoan parasite Trypanosoma cruzi is the etiologic agent of Chagas' disease, an illness that causes severe morbidity and death among millions of Latin Americans. The most common, and most serious, adverse effect of chronic infection with this parasite is Chagas heart disease (CHD), a dilated cardiomyopathy of uncertain etiology. A number of mechanisms have been proposed for the pathogenesis of CHD, two of which are the subject of considerable controversy. Because parasites are scarce in or absent from the heart tissues of Chagas' patients who succumb to heart failure, autoimmunity has been proposed to be responsible for disease pathogenesis. More sensitive techniques, such as in situ PCR and immunohistochemistry, have been used to analyze these hearts and, indeed, parasite DNA and antigen are present. These findings support the hypothesis that parasite-induced damage plus host immunity to parasite antiqens is the inflammatory stimulus. Another confounding factor is that different combinations of parasite and animal strains give different outcomes, which, in actuality, is reflective of the human disease. To test the autoimmunity hypothesis for CHD pathogenesis, while simultaneously considering the parasite immunity hypothesis, we developed a mouse model of CHD (T. cruzi Brazil strain infection of male A/J mice) in which strong cardiac autoimmunity and parasite-specific immunity rapidly develop upon infection. Our research during the past several years indicates that (i) cardiac autoimmunity develops upon infection that is of similar magnitude and quality as that induced by immunization with cardiac proteins in adjuvant (purely autoimmune), (ii) autoimmunity involving a number of cardiac antigens develops in infected animals, (iii) autoimmunity to cardiac myosin may develop via the mechanisms of molecular mimicry and bystander activation, and (iv) selective suppression of myosin autoimmunity does not eliminate tissue inflammation in infected animals, suggesting that other autoimmune responses may be significant and/or that parasite-specific immunity hypothesis is sufficient to give tissue inflammation. The Specific Aims of our research are (i) to investigate the molecular mimicry mechanism of myosin autoimmunity in CHD, (ii) to identify additional cardiac auto-antigens and determine their roles in CHD pathogenesis and (iii) to test the autoimmune and parasite immune hypotheses for CHD pathogenesis.
描述(由申请方提供):原生动物寄生虫克氏锥虫是南美锥虫病的病原体,南美锥虫病是一种导致数百万拉丁美洲人严重发病和死亡的疾病。这种寄生虫慢性感染最常见和最严重的不良反应是查加斯心脏病(CHD),一种病因不明的扩张型心肌病。冠心病的发病机制有很多种,其中有两种机制存在很大争议。由于寄生虫在死于心力衰竭的恰加斯病患者的心脏组织中很少或不存在,因此已提出自身免疫是疾病发病机制的原因。更敏感的技术,如原位PCR和免疫组织化学,已被用来分析这些心脏,确实,寄生虫DNA和抗原的存在。这些发现支持了寄生虫引起的损伤加上宿主对寄生虫抗原的免疫是炎症刺激的假设。另一个混淆因素是寄生虫和动物菌株的不同组合产生不同的结果,这实际上反映了人类疾病。为了验证CHD发病机制的自身免疫假说,同时考虑寄生虫免疫假说,我们建立了CHD小鼠模型(T。cruzi巴西株感染的雄性A/J小鼠),其中在感染后迅速产生强的心脏自身免疫和寄生虫特异性免疫。我们在过去几年的研究表明,(i)心脏自身免疫 在感染后发生,其程度和质量与用佐剂中的心脏蛋白免疫诱导的感染相似(纯粹的自身免疫),(ii)在感染的动物中发展涉及许多心脏抗原的自身免疫,(iii)对心脏肌球蛋白的自身免疫可通过分子模拟和旁观者激活机制发展,和(iv)选择性抑制肌球蛋白自身免疫不能消除感染动物的组织炎症,提示其他自身免疫应答可能是显著的和/或寄生虫特异性免疫假说足以引起组织炎症。我们的研究的具体目的是(i)研究CHD中肌球蛋白自身免疫的分子模拟机制,(ii)鉴定其他心脏自身抗原并确定其在CHD发病机制中的作用,(iii)测试CHD发病机制的自身免疫和寄生虫免疫假说。

项目成果

期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

David M. Engman其他文献

Meesmann corneal dystrophy
梅斯曼角膜营养不良
  • DOI:
  • 发表时间:
    2020
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Mark Oette;Marvin J. Stone;H. Scholl;Peter Charbel Issa;M. Fleckenstein;Steffen Schmitz;Frank G. Holz;O. Strauss;Jörg;Michael Fromm;Tommie V. McCarthy;Meinhard Schiller;Stephan Grabbe;C. Sunderkötter;Gidon Almogy;Avraham I. Rivkind;Hideaki Kato;John W. Finley;Johannes Uhl;Jürgen Kopitz;Michael Cantz;Philip F. Giampietro;Inga Harting;Nicole I. Wolf;Jürgen Grabbe;Robert J. Beynon;Rosaline C. M. Quinlivan;Caroline A. Sewry;Naoto Kuroda;Cengiz Korkmaz;Anthony J. Bleyer;Thomas C. Hart;Michele Bisceglia;Carlos Galliani;Stefan Pfister;Olaf Witt;Alexander K. C. Leung;Jan Hellemans;Geert Mortier;M. Schmitt;Markus Pfister;Hans;Markus J. Riemenschneider;Guido Reifenberger;Julian F. B. Mercer;Sharon La Fontaine;Ingrid Moll;Bruce C. Kone;Stephan vom Dahl;P. Schwarz;Jiang Li;Volkmar Gieselmann;David Genevieve;Martine Le Merrer;John;Victor E. A. Gerdes;K. Beyer;Elardus Erasmus;Lodewyk J. Mienie;Jan Bubeník;Jana Šímová;Thorsten Buch;Ansgar Schulz;Irmgard Förster;Shirley Hodgson;Holger Sudhoff;Peter J. Goadsby;Karin Jurkat;Frank Lehmann;John Logan;Bernadette McGuinness;Maria Isabel Melaragno;Marcial Francis Galera;Hardally R. Hegde;Hannu Jalanko;Maria Judit Molnar;Danae Liolitsa;Charungthai Dejthevaporn;Michael G. Hanna;Josef Finsterer;Yuichi Goto;Lucia K. Ma;Patrick T. S. Ma;Toshio Nishikimi;Siobhan D. Ma;Andrew Rozelle;E. Chakravarty;Stefan R. Bornstein;Sven Schinner;Marinus Duran;William Lane M. Robson;Christine Liang;Julie V. Schaffer;Claudiu Plesa;Franck E. Nicolini;Eric Sibley;Vinzenz Oji;Heiko Traupe;Damian Miles Bailey;Heimo Mairbäurl;Peter Bärtsch;Alexander K. C. Leung;Justine H. S. Fong;M. Beck;Silke Hofmann;Leena Bruckner;Dieter Metze;Riikka H. Hämäläinen;Anna;Marita Lipsanen;Constantine A. Stratakis;Francesca Marini;Alberto Falchetti;Maria Luisa Brandi;Christian Bender Koch;Constantine A. Stratakis;Michael Briggs;Wim Wuyts;Filip Vanhoenacker;Wim Hul;Hayrettin Tumani;Kurt Von Figura;Thomas Dierks;Bernhard Schmidt;Luca Busetto;Giuliano Enzi;Thomas Klockgether;Ioannis Stefanidis;Georgios M. Hadjigeorgiou;Klaus Zerres;Sabine Rudnik‐Schöneborn;Hans;Anne;Eric P. Hoffman;Rabah Ben Yaou;Gisèle Bonne;Dominique Récan;Peter Hackman;Bjarne Udd;Wolfgang Dietmaier;Arndt Hartmann;Dominique Prié;Caroline Silve;Bernard Grandchamp;Gérard Friedlander;Andrew G. Engel;W. Kempf;R. Dummer;Günter Burg;Daniela Cilloni;Giuseppe Saglio;Ulrich S. Schuler;Ulrike Bacher;Claudia Haferlach;Susanne Schnittger;Torsten Haferlach;Reginald S. Sauve;Deepak Kamat;Stephen N. Makoni;Richard L. Sabina;Benjamin D. Tyrrell;Justin A. Ezekowitz;Wolfgang Schillinger;G. Hasenfuss;Kevin M. Bonney;David M. Engman;Thomas Klopstock;Friedrich Asmus;Thomas Gasser;Dina J. Zand;Elaine H. Zackai;Frank Schaeffel;Anders Oldfors;Niklas Darin;Tommy Martinsson;Ursula Knirsch;Gisela Stoltenburg;Olayinka Raheem;Tiina Suominen
  • 通讯作者:
    Tiina Suominen
Efficacy of benznidazole delivery during Chagas disease nanotherapy is dependent on the nanocarrier morphology
在恰加斯病纳米治疗期间,苄硝唑递送的功效取决于纳米载体的形态
  • DOI:
    10.1016/j.biomaterials.2025.123358
  • 发表时间:
    2025-11-01
  • 期刊:
  • 影响因子:
    12.900
  • 作者:
    Debora B. Scariot;Austeja Staneviciute;Rayanne R.B. Machado;Simseok A. Yuk;Yu-Gang Liu;Swagat Sharma;Sultan Almunif;El Hadji Arona Mbaye;Celso Vataru Nakamura;David M. Engman;Evan A. Scott
  • 通讯作者:
    Evan A. Scott

David M. Engman的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('David M. Engman', 18)}}的其他基金

Global Characterization of Protein Palmitoylation in Trypanosomes
锥虫中蛋白质棕榈酰化的整体表征
  • 批准号:
    8685282
  • 财政年份:
    2013
  • 资助金额:
    $ 27.01万
  • 项目类别:
Global Characterization of Protein Palmitoylation in Trypanosomes
锥虫中蛋白质棕榈酰化的整体表征
  • 批准号:
    8504116
  • 财政年份:
    2013
  • 资助金额:
    $ 27.01万
  • 项目类别:
Global Characterization of Protein Palmitoylation in Trypanosomes
锥虫中蛋白质棕榈酰化的整体表征
  • 批准号:
    8829304
  • 财政年份:
    2013
  • 资助金额:
    $ 27.01万
  • 项目类别:
Pathogenesis of Experimental Autoimmune Myocarditis
实验性自身免疫性心肌炎的发病机制
  • 批准号:
    7339181
  • 财政年份:
    2006
  • 资助金额:
    $ 27.01万
  • 项目类别:
Pathogenesis of Experimental Autoimmune Myocarditis
实验性自身免疫性心肌炎的发病机制
  • 批准号:
    7860722
  • 财政年份:
    2006
  • 资助金额:
    $ 27.01万
  • 项目类别:
Pathogenesis of Experimental Autoimmune Myocarditis
实验性自身免疫性心肌炎的发病机制
  • 批准号:
    7150838
  • 财政年份:
    2006
  • 资助金额:
    $ 27.01万
  • 项目类别:
Pathogenesis of Experimental Autoimmune Myocarditis
实验性自身免疫性心肌炎的发病机制
  • 批准号:
    7424971
  • 财政年份:
    2006
  • 资助金额:
    $ 27.01万
  • 项目类别:
Pathogenesis of Experimental Autoimmune Myocarditis
实验性自身免疫性心肌炎的发病机制
  • 批准号:
    7624645
  • 财政年份:
    2006
  • 资助金额:
    $ 27.01万
  • 项目类别:
Pathogenesis of Experimental Autoimmune Myocarditis
实验性自身免疫性心肌炎的发病机制
  • 批准号:
    7271228
  • 财政年份:
    2006
  • 资助金额:
    $ 27.01万
  • 项目类别:
Pathogenesis of Chagas Heart Disease
恰加斯心脏病的发病机制
  • 批准号:
    6999368
  • 财政年份:
    2004
  • 资助金额:
    $ 27.01万
  • 项目类别:

相似海外基金

Blood transcriptomics as CT adjuvant to exclude hemorrhage in acute stroke
血液转录组学作为 CT 佐剂排除急性中风出血
  • 批准号:
    10611988
  • 财政年份:
    2020
  • 资助金额:
    $ 27.01万
  • 项目类别:
Blood transcriptomics as CT adjuvant to exclude hemorrhage in acute stroke
血液转录组学作为 CT 佐剂排除急性中风出血
  • 批准号:
    10396630
  • 财政年份:
    2020
  • 资助金额:
    $ 27.01万
  • 项目类别:
Blood transcriptomics as CT adjuvant to exclude hemorrhage in acute stroke
血液转录组学作为 CT 佐剂排除急性中风出血
  • 批准号:
    10210310
  • 财政年份:
    2020
  • 资助金额:
    $ 27.01万
  • 项目类别:
An Evaluation of Adjuvant Treatments to Mechanical Ventilation for Acute Respiratory Failure
机械通气治疗急性呼吸衰竭辅助治疗的评价
  • 批准号:
    319456
  • 财政年份:
    2014
  • 资助金额:
    $ 27.01万
  • 项目类别:
    Fellowship Programs
ACUTE OTITIS MEDIA--ADJUVANT THERAPY TO IMPROVE OUTCOME
急性中耳炎——改善疗效的辅助治疗
  • 批准号:
    6566709
  • 财政年份:
    2001
  • 资助金额:
    $ 27.01万
  • 项目类别:
ACUTE OTITIS MEDIA--ADJUVANT THERAPY TO IMPROVE OUTCOME
急性中耳炎——改善疗效的辅助治疗
  • 批准号:
    6413648
  • 财政年份:
    2000
  • 资助金额:
    $ 27.01万
  • 项目类别:
ACUTE OTITIS MEDIA--ADJUVANT THERAPY TO IMPROVE OUTCOME
急性中耳炎——改善疗效的辅助治疗
  • 批准号:
    6305272
  • 财政年份:
    1999
  • 资助金额:
    $ 27.01万
  • 项目类别:
ACUTE OTITIS MEDIA--ADJUVANT THERAPY TO IMPROVE OUTCOME
急性中耳炎——改善疗效的辅助治疗
  • 批准号:
    6115194
  • 财政年份:
    1998
  • 资助金额:
    $ 27.01万
  • 项目类别:
ACUTE OTITIS MEDIA--ADJUVANT THERAPY TO IMPROVE OUTCOME
急性中耳炎——改善疗效的辅助治疗
  • 批准号:
    6276403
  • 财政年份:
    1997
  • 资助金额:
    $ 27.01万
  • 项目类别:
ACUTE OTITIS MEDIA--ADJUVANT THERAPY TO IMPROVE OUTCOME
急性中耳炎——改善疗效的辅助治疗
  • 批准号:
    6276429
  • 财政年份:
    1997
  • 资助金额:
    $ 27.01万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了